EW
Edwards Lifesciences Corporation
Stock
$85.15−0.04 (−0.05%)Close Oct 2, 2026
- Revenue, 2025
- $6.1B
- YoY, 2025
- +11.5%
- 5-year CAGR
- +6.7%
- 10-year CAGR
- +9.3%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $6.1B | +11.5% |
| 2024 | $5.4B | +8.6% |
| 2023 | $5.0B | +12.2% |
| 2022 | $4.5B | −14.7% |
| 2021 | $5.2B | +19.3% |
| 2020 | $4.4B | +0.9% |
| 2019 | $4.3B | +16.8% |
| 2018 | $3.7B | +8.4% |
| 2017 | $3.4B | +15.9% |
| 2016 | $3.0B | +18.8% |
| 2015 | $2.5B | +7.4% |
| 2014 | $2.3B | +13.6% |
| 2013 | $2.0B | +7.7% |
| 2012 | $1.9B | +13.2% |
| 2011 | $1.7B | +16.0% |
| 2010 | $1.4B | +9.5% |
| 2009 | $1.3B | +6.8% |
| 2008 | $1.2B | — |